Back to Agenda
Opening Plenary - Transactional to Transformational Safety Ecosystem - The Future of Pharmacovigilance
Session Chair(s)
Krishna Bahadursingh
Head of Patient Safety
Bristol Myers Squibb, Japan
If there was any proof required to showcase future of PV, the current pandemic exhibited and provided evidences about transformation of safety ecosystem. The challenge facing healthcare science today in developing safe medicines for unmet newer medical catastrophe at unprecedented speed and deliver molecules which are not only efficacious but safe as well is enormous. Its quite evident that In addition to the conventional methods and pathways, the involvement & contribution of evolving technological tools such as Artificial Intelligence, and Pharmacogenomics would be the key players in transforming safety ecosystem for a better & safer tomorrow
Speaker(s)
Contributing Panelist
Sanjay Vyas
Head - Safety Services & Logistics, Parexel , India
Executive Vice President, India Country Head & Managing Director, Global SBU
Contributing Panelist
Nilima Kshirsagar
ICMR, India
National Chair Clinical Pharmacology
Contributing Panelist
Thomas Nisslein
Pharmacovigilance Established Pharmaceuticals, Abbott Laboratories GmbH, Germany
Director Global Pharmacovigilance and EU QPPV, Innovation & Development - Global
Contributing Panelist
Nipom Deka
Amgen Inc., United States
Global Safety Medical Director, Immuno-Oncology Therapeutic Area
Have an account?